Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes (Q42819169)

7 November 2017

Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes (English)

1 reference

7 November 2017

1 reference

1 reference

1 reference

T Sasaoka

1

1 reference

7 November 2017

K Fukui

2

1 reference

7 November 2017

T Wada

3

1 reference

7 November 2017

S Murakami

4

1 reference

7 November 2017

J Kawahara

5

1 reference

7 November 2017

H Ishihara

6

1 reference

7 November 2017

M Funaki

7

1 reference

7 November 2017

T Asano

8

1 reference

7 November 2017

M Kobayashi

9

1 reference

7 November 2017

15 January 2005

1 reference

7 November 2017

1 reference

7 November 2017

48

1 reference

7 November 2017

336-344

1 reference

7 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1636-8

7 November 2017

0 references

cites work

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

1 reference

12 December 2020

The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man

1 reference

12 December 2020

Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity

1 reference

12 December 2020

The lipid phosphatase SHIP2 controls insulin sensitivity

1 reference

12 December 2020

Signaling pathways in insulin action: molecular targets of insulin resistance

1 reference

12 December 2020

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

1 reference

12 December 2020

Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport

1 reference

12 December 2020

Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1

1 reference

12 December 2020

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts

1 reference

12 December 2020

Rapamycin partially prevents insulin resistance induced by chronic insulin treatment

1 reference

12 December 2020

Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells

1 reference

12 December 2020

Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes

1 reference

12 December 2020

Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance.

1 reference

12 December 2020

Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice

1 reference

12 December 2020

Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction

1 reference

12 December 2020

Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP

1 reference

12 December 2020

Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes

1 reference

12 December 2020

Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin

1 reference

12 December 2020

Development of insulin resistance in 3T3-L1 adipocytes

1 reference

12 December 2020

Signaling mechanisms that regulate glucose transport

1 reference

12 December 2020

Insulin signaling pathways in time and space.

1 reference

12 December 2020

Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport

1 reference

12 December 2020

The role of phosphoinositide 3-kinase lipid products in cell function

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

The phosphoinositide 3-kinase pathway

1 reference

12 December 2020

Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10

1 reference

12 December 2020

Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors

1 reference

12 December 2020

A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

1 reference

12 December 2020

Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes

1 reference

12 December 2020

Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes

1 reference

12 December 2020

Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling

1 reference

12 December 2020

10.1007/S00125-004-1636-8

Identifiers

DOI

1 reference

7 November 2017

1 reference